biotechnology

• 

  U.S. stocks erase gains as finance chiefs meet on Greece aid

  By Nikolaj Gammeltoft and Alexis Xydias, Bloomberg  |  November 12, 2012

  U.S. stocks erased gains, failing to rebound after the Standard & Poor’s 500 Index’s biggest weekly retreat since June, as investors awaited budget talks in Washington and European finance chiefs met to discuss Greek aid.

• 

  U.S. stocks little changed as investors monitor economic data

  By Rita Nazareth, Bloomberg  |  October 26, 2012

  U.S. stocks were little changed, with the Standard & Poor’s 500 Index on pace for a weekly decline, as investors watched economic and earnings reports.

• Oncothyreon falls after Merck cancer drug delayed

  By Canaccord Genuity Morning Coffee  |  March 7, 2012

  Biotechnology company Oncothyreon showed resource stocks how a selloff is done properly, following word that its most advanced drug candidate, a cancer treatment, will not be released until next year.

• Gann analysis points way for stock market miracles

  By Jeff Greenblatt  |  December 12, 2011

  Weekly technical outlook of financial markets featuring Lucas Wave, Gann analysis and Fibonacci theory.

• Henry Jarecki: Jarecki’s law

  By Daniel P. Collins  |  May 1, 2011

  Henry Jarecki has been dealing in metals since before the United States allowed gold to trade freely

• New volatility index designed for risk management

  By Press Release  |  August 26, 2010

  The index dynamically adjusts exposure to the Nasdaq 100 index using a "volatility control mechanism."

• Equity indexes: A guide for beginners

  By Laura Oatney  |  May 13, 2010

  A history and guide to equity indexes and how they are composed and traded.